Production assistance for cellular therapies (pact)- cell processing facilities
Ended Awarded Last action
- Contract number
- HHSN268201600012I
- Awardee
-
University Of Miami UEI F8THLJQSAF93 Part of University Of Miami
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 11 $5,254,284 obligated
Award facts
- Opportunity
-
- NHLBIECBHB201609JB Solicitation number
- Combined order value
-
- $5,254,284 Current, with exercised options
- $5,784,291 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 12% used
- $45,630,651.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- 10 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities indefinite delivery contract, awarded by the National Heart, Lung and Blood Institute (NHLBI) to the University of Miami Office of Research Administration - School of Medicine Division on July 29, 2016, provides a multiple-award vehicle with a ceiling value of $45.6 million and ultimate completion date of June 30, 2022. The contract was awarded without set-aside designation under full and open competition and is performed at the University of Miami's facilities in South Miami, Florida. This indefinite delivery contract structure allows the NHLBI to issue task orders for specialized cell manufacturing and process development services that support the agency's regenerative medicine and cellular therapy research initiatives. The contract does not specify a set-aside category, reflecting its competitive procurement approach.
The task orders issued against this PACT-CPF master contract demonstrate the breadth of cellular therapy manufacturing services delivered by the University of Miami, including induced pluripotent stem cell (iPSC) line production, cardiac progenitor cell scale-up operations, iPSC-derived cardiomyocyte bank manufacturing, cryopreservation technical studies, mesenchymal stromal cell (MSC) processing from Wharton's jelly for bronchopulmonary dysplasia research, MSC-derived exosome manufacturing scale-up, fibroblast master and working cell bank production, and product quality improvement initiatives. Individual delivery orders range from approximately $185,000 to $1.18 million, with cost-no-fee and firm-fixed-price pricing structures. These task orders, awarded between August 2016 and December 2019, support the NHLBI's mission to advance cellular therapeutic development through access to specialized cell processing facilities and expertise, enabling rigorous manufacturing and testing of cell-based therapies for cardiovascular and pulmonary diseases.
Task orders
Show all 11
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN268201600012I?
HHSN268201600012I was awarded to University Of Miami by National Heart Lung and Blood Institute (National Institutes of Health) on July 29, 2016.
How much is contract HHSN268201600012I worth?
Orders under HHSN268201600012I have obligated $5,254,284. Their combined potential value, with all options, is $5,784,291. HHSN268201600012I's own ceiling is $45,630,651.
How many orders have been placed under contract HHSN268201600012I?
11 orders have been placed under HHSN268201600012I, the latest on December 10, 2019.
Who can order from contract HHSN268201600012I?
HHSN268201600012I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN268201600012I part of a contract vehicle?
Yes. HHSN268201600012I is part of Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF).
Was contract HHSN268201600012I competed?
The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV